Pure Biologics S.A. (FRA:PQB)
Germany · Delayed Price · Currency is EUR 0.9280
+0.2215 (31.35%)
At close: Nov 28, 2025
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of €7.86 million as of December 1, 2025. Its market cap has decreased by -51.01% in one year.
Market Cap
7.86M
Enterprise Value
11.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.93
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 6.24M to 7.86M, an increase of 25.87%. That is a compound annual growth rate of 3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 3.95M | -73.79% |
| Dec 30, 2024 | 15.09M | 55.88% |
| Dec 29, 2023 | 9.68M | -12.63% |
| Dec 30, 2022 | 11.08M | -71.01% |
| Dec 30, 2021 | 38.22M | -5.06% |
| Dec 30, 2020 | 40.26M | 203.80% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |